Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Proteomics Market Across the Globe
4.2.2 Increasing R&D Investment by the Pharma and Biotech Companies
4.2.3 Wide Applications of the Western Blot Test
4.3 Market Restraints
4.3.1 Availability of the Alternatives for Western Blot
4.3.2 Accuracy Issues
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Instruments
5.1.1.1 Gel Electrophoresis Instruments
5.1.1.2 Blotting Systems
5.1.1.3 Imagers
5.1.1.3.1 Chemiluminescent Imagers
5.1.1.3.2 Fluorescent Imagers
5.1.1.3.3 Others
5.1.2 Consumables
5.1.2.1 Reagents
5.1.2.2 Kits
5.2 By Application
5.2.1 Biomedical & Biochemical Research
5.2.2 Disease Diagnostics
5.2.3 Others
5.3 By End-User
5.3.1 Academia and Research Institutes
5.3.2 Diagnostic Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bio-Rad Laboratories, Inc.
6.1.2 Thermo Fisher Scientific, Inc.
6.1.3 LI-COR Biosciences
6.1.4 Bio-Techne Corporation
6.1.5 Merck KGaA
6.1.6 PerkinElmer, Inc.
6.1.7 Cell Signaling Technology
6.1.8 Advansta, Inc.
6.1.9 Danaher Corporation


7 MARKET OPPORTUNITIES AND FUTURE TRENDS